Transcatheter mitral valve replacement with the NaviGate stent in a preclinical model

EuroIntervention 2017;13:e1401-e1409 published online September 2017 published online e-edition December 2017. DOI: 10.4244/EIJ-D-17-00210

Jose L. Navia
Jose L. Navia1*, MD; Cristian Baeza2, MD; Gabriel Maluenda2, MD; Samir Kapadia3, MD; Haytham Elgharably1, MD; Jerzy Sadowski4, MD; Krzysztof Bartuś4, MD; Cesare Beghi5, MD; Kalathi Thyagarajan6, PhD; Ryan Bertwell6, ME; Rodolfo C. Quijano6, MD, PhD
1. Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA; 2. Hospital San Borja Arriaran, Santiago, Chile; 3. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA; 4. Jagiellonian University, Depart

Aims: The aim of this study was to test the feasibility of transcatheter mitral valve implantation of the NaviGate device in acute and chronic preclinical models.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

dyspnoeamiscellaneousmitral valve repairvalve-in-valve
Read next article
Acute performance of a novel restorative transcatheter aortic valve: preclinical results

Latest news